Pancreatic cancer has long been one of medicine's most stubborn adversaries, a disease so aggressive and so difficult to detect in its early stages that it is often described as the "king of cancers." The most common form, pancreatic ductal adenocarcinoma, carries a five-year survival rate of only about 13 percent, and
Pancreatic cancer has long been one of medicine's most stubborn adversaries, a disease so aggressive and so difficult to detect in its early stages that it is often described as the "king of cancers." The...
The page is ready to read now. The fuller skim-friendly version will appear here automatically.
Pancreatic cancer has long been one of medicine's most stubborn adversaries, a disease so aggressive and so difficult to detect in its early stages that it is often described as the "king of cancers." The most common form, pancreatic ductal adenocarcinoma, carries a five-year survival rate of only about 13 percent, and
Open the app view to save this story, compare related coverage, and continue from the same source.